BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25265348)

  • 21. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
    Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
    Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive oxygen species mediate Endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells.
    Daou GB; Srivastava AK
    Free Radic Biol Med; 2004 Jul; 37(2):208-15. PubMed ID: 15203192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1.
    Hvid H; Fels JJ; Kirk RK; Thorup I; Jensen HE; Hansen BF; Oleksiewicz MB
    Toxicol Pathol; 2011 Jun; 39(4):623-40. PubMed ID: 21558470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways.
    Raucci A; Bellosta P; Grassi R; Basilico C; Mansukhani A
    J Cell Physiol; 2008 May; 215(2):442-51. PubMed ID: 17960591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P; Loomis R; Carbone R; Srimatkandada S; Lacy J
    Eur J Haematol; 2008 May; 80(5):407-18. PubMed ID: 18221384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome.
    Plunkett FJ; Franzese O; Belaramani LL; Fletcher JM; Gilmour KC; Sharifi R; Khan N; Hislop AD; Cara A; Salmon M; Gaspar HB; Rustin MH; Webster D; Akbar AN
    Mech Ageing Dev; 2005 Aug; 126(8):855-65. PubMed ID: 15992610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
    Nagy N; Klein E
    Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.
    Yasuda N; Lai PK; Rogers J; Purtlo DT
    Clin Exp Immunol; 1991 Jan; 83(1):10-6. PubMed ID: 1846327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.
    Ma CS; Hare NJ; Nichols KE; Dupré L; Andolfi G; Roncarolo MG; Adelstein S; Hodgkin PD; Tangye SG
    J Clin Invest; 2005 Apr; 115(4):1049-59. PubMed ID: 15761493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
    Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
    Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligation of beta4 integrins activates PKB/Akt and ERK1/2 by distinct pathways-relevance of the keratin filament.
    Kippenberger S; Hofmann M; Zöller N; Thaçi D; Müller J; Kaufmann R; Bernd A
    Biochim Biophys Acta; 2010 Aug; 1803(8):940-50. PubMed ID: 20307589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL).
    O'Hayre M; Niederst M; Fecteau JF; Nguyen VM; Kipps TJ; Messmer D; Newton AC; Handel TM
    Leukemia; 2012 Jul; 26(7):1689-92. PubMed ID: 22237780
    [No Abstract]   [Full Text] [Related]  

  • 35. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.
    Yurchenko MY; Kovalevska LM; Shlapatska LM; Berdova GG; Clark EA; Sidorenko SP
    Immunol Cell Biol; 2010 Jul; 88(5):565-74. PubMed ID: 20231852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease.
    Nagy N; Matskova L; Kis LL; Hellman U; Klein G; Klein E
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11966-71. PubMed ID: 19570996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased lymphocyte viability after non-stimulated peripheral blood mononuclear cell (PBMC) culture in patients with X-linked lymphoproliferative disease (XLP).
    Belmonte L; Parodi C; Bastón M; Coraglia A; Felippo M; Baré P; Malbrán A; Ruibal-Ares B; de E de Bracco MM
    Clin Immunol; 2009 Oct; 133(1):86-94. PubMed ID: 19576857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-linked lymphoproliferative disease in an adult.
    Hoshino T; Kanegane H; Doki N; Irisawa H; Sakura T; Nojima Y; Miyawaki S; Miyawaki T
    Int J Hematol; 2005 Jul; 82(1):55-8. PubMed ID: 16105760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.